T. Rowe Price Investment Management
GBIO

T. Rowe Price Investment Management’s Generation Bio GBIO Stock Holding History

T. Rowe Price Investment Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-351,146
Closed -$13.3M – 613
2023
Q3 		$13.3M Hold
351,146
– – 0.01% 510
2023
Q2 		$19.3M Buy
351,146
+13,050
+4% +$599K 0.01% 481
2023
Q1 		$14.5M Sell
338,096
-19,680
-6% -$952K 0.01% 494
2022
Q4 		$14.1M Buy
357,776
+9,514
+3% +$500K 0.01% 490
2022
Q3 		$18.5M Buy
+348,262
New +$21.8M 0.01% 461

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Investment Management's GBIO Position: Q4 2023 in Review

T. Rowe Price Investment Management sold out of Generation Bio (GBIO) in Q4 2023, closing a stake of 351,146 shares — an estimated $13.3M sold.

T. Rowe Price Investment Management first reported a position in GBIO in Q3 2022 and held it in 5 quarters. The position peaked at $19.3M in Q2 2023. 74 funds tracked by Wall St. Rank hold GBIO as of Q4 2023.

  • T. Rowe Price Investment Management reported no remaining Generation Bio position as of Q4 2023 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 351,146 Generation Bio shares in Q4 2023, an estimated $13.3M.
  • T. Rowe Price Investment Management first reported a position in Generation Bio in Q3 2022 and held it in 5 quarters.
  • T. Rowe Price Investment Management's Generation Bio position peaked at $19.3M in Q2 2023.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q4 2023.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.